 Brent Palmer
Concepts (451)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD4-Positive T-Lymphocytes | 34 | 2021 | 984 | 3.820 |
Why?
| | HIV Infections | 35 | 2022 | 2459 | 3.720 |
Why?
| | Gastrointestinal Microbiome | 6 | 2024 | 548 | 1.940 |
Why?
| | Homosexuality, Male | 4 | 2022 | 166 | 1.680 |
Why?
| | Sexual and Gender Minorities | 4 | 2022 | 137 | 1.640 |
Why?
| | HIV-1 | 17 | 2018 | 776 | 1.630 |
Why?
| | Microbiota | 7 | 2022 | 656 | 1.560 |
Why?
| | HIV | 5 | 2019 | 210 | 1.450 |
Why?
| | Programmed Cell Death 1 Receptor | 11 | 2019 | 197 | 1.300 |
Why?
| | Dysbiosis | 3 | 2021 | 147 | 1.090 |
Why?
| | Virus Replication | 5 | 2010 | 405 | 1.050 |
Why?
| | Epitopes, T-Lymphocyte | 6 | 2010 | 170 | 1.000 |
Why?
| | CD8-Positive T-Lymphocytes | 16 | 2021 | 702 | 0.990 |
Why?
| | Receptors, CCR5 | 4 | 2021 | 54 | 0.990 |
Why?
| | Lymphocyte Activation | 16 | 2018 | 1067 | 0.980 |
Why?
| | Feces | 4 | 2021 | 396 | 0.940 |
Why?
| | Antigens, CD | 9 | 2020 | 460 | 0.860 |
Why?
| | Berylliosis | 6 | 2013 | 183 | 0.840 |
Why?
| | Gastrointestinal Tract | 2 | 2014 | 175 | 0.820 |
Why?
| | Viral Load | 9 | 2020 | 419 | 0.810 |
Why?
| | Firmicutes | 1 | 2021 | 20 | 0.780 |
Why?
| | Macrophages, Alveolar | 3 | 2020 | 359 | 0.770 |
Why?
| | T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2020 | 7 | 0.740 |
Why?
| | Anti-Inflammatory Agents | 3 | 2022 | 465 | 0.740 |
Why?
| | Antiretroviral Therapy, Highly Active | 7 | 2016 | 260 | 0.730 |
Why?
| | Up-Regulation | 9 | 2019 | 872 | 0.710 |
Why?
| | Germ-Free Life | 1 | 2019 | 30 | 0.700 |
Why?
| | Inflammation | 7 | 2022 | 2566 | 0.680 |
Why?
| | Varicellovirus | 4 | 2022 | 28 | 0.670 |
Why?
| | Leukocytes, Mononuclear | 7 | 2022 | 509 | 0.660 |
Why?
| | Apoptosis Regulatory Proteins | 3 | 2008 | 190 | 0.650 |
Why?
| | T-Lymphocyte Subsets | 10 | 2016 | 396 | 0.610 |
Why?
| | CD57 Antigens | 3 | 2007 | 14 | 0.600 |
Why?
| | Anti-HIV Agents | 5 | 2016 | 664 | 0.600 |
Why?
| | B7-H1 Antigen | 6 | 2019 | 144 | 0.590 |
Why?
| | Beryllium | 6 | 2009 | 151 | 0.580 |
Why?
| | Cytokines | 12 | 2021 | 1900 | 0.560 |
Why?
| | Interferon-gamma | 13 | 2013 | 736 | 0.560 |
Why?
| | Lung | 16 | 2022 | 3662 | 0.550 |
Why?
| | Intestinal Mucosa | 1 | 2021 | 531 | 0.550 |
Why?
| | Cord Blood Stem Cell Transplantation | 1 | 2016 | 96 | 0.530 |
Why?
| | Bacteria | 4 | 2022 | 757 | 0.520 |
Why?
| | Viremia | 5 | 2018 | 132 | 0.510 |
Why?
| | Humans | 83 | 2024 | 118931 | 0.510 |
Why?
| | T-Lymphocytes, Regulatory | 7 | 2021 | 359 | 0.490 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2022 | 1171 | 0.490 |
Why?
| | Biota | 1 | 2013 | 37 | 0.460 |
Why?
| | B-Lymphocytes | 7 | 2022 | 770 | 0.460 |
Why?
| | Immunophenotyping | 9 | 2020 | 278 | 0.450 |
Why?
| | Bronchoalveolar Lavage Fluid | 9 | 2020 | 613 | 0.440 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 2 | 2009 | 18 | 0.430 |
Why?
| | Herpesviridae Infections | 4 | 2019 | 142 | 0.430 |
Why?
| | T-Lymphocytes | 9 | 2018 | 1774 | 0.430 |
Why?
| | Down-Regulation | 2 | 2016 | 627 | 0.400 |
Why?
| | Interleukin-2 | 5 | 2013 | 416 | 0.380 |
Why?
| | Adult | 29 | 2020 | 31508 | 0.380 |
Why?
| | Herpes Zoster | 4 | 2022 | 336 | 0.380 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2019 | 514 | 0.380 |
Why?
| | Herpesvirus 3, Human | 4 | 2022 | 389 | 0.370 |
Why?
| | Anti-Retroviral Agents | 3 | 2018 | 208 | 0.360 |
Why?
| | Gene Products, gag | 3 | 2016 | 38 | 0.350 |
Why?
| | Receptors, OX40 | 1 | 2009 | 15 | 0.350 |
Why?
| | Middle Aged | 25 | 2020 | 27607 | 0.350 |
Why?
| | Male | 34 | 2022 | 57784 | 0.340 |
Why?
| | Interleukin-10 | 4 | 2022 | 306 | 0.340 |
Why?
| | Antibodies, Viral | 4 | 2022 | 542 | 0.340 |
Why?
| | Virus Activation | 3 | 2019 | 80 | 0.320 |
Why?
| | Membrane Proteins | 3 | 2013 | 1055 | 0.320 |
Why?
| | Chronic Disease | 9 | 2014 | 1633 | 0.320 |
Why?
| | Immune System | 2 | 2019 | 181 | 0.310 |
Why?
| | Vaccination | 3 | 2021 | 1221 | 0.310 |
Why?
| | Dendritic Cells | 8 | 2019 | 442 | 0.310 |
Why?
| | Meningitis, Cryptococcal | 2 | 2020 | 28 | 0.300 |
Why?
| | Female | 33 | 2023 | 61547 | 0.300 |
Why?
| | Immunologic Factors | 2 | 2022 | 225 | 0.300 |
Why?
| | Cerebrospinal Fluid | 2 | 2020 | 93 | 0.300 |
Why?
| | Sexual Behavior | 3 | 2020 | 437 | 0.290 |
Why?
| | Vitiligo | 2 | 2019 | 75 | 0.290 |
Why?
| | Cohort Studies | 8 | 2019 | 5116 | 0.290 |
Why?
| | Interleukin-1 | 3 | 2019 | 980 | 0.290 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2010 | 632 | 0.280 |
Why?
| | Immunity, Innate | 3 | 2019 | 745 | 0.260 |
Why?
| | DNA, Bacterial | 2 | 2019 | 314 | 0.260 |
Why?
| | Gene Expression | 1 | 2010 | 1488 | 0.260 |
Why?
| | Interleukin-12 | 2 | 2022 | 110 | 0.240 |
Why?
| | Autoimmune Diseases | 2 | 2019 | 398 | 0.240 |
Why?
| | Animals | 25 | 2022 | 33381 | 0.240 |
Why?
| | Fetomaternal Transfusion | 1 | 2023 | 10 | 0.240 |
Why?
| | Young Adult | 9 | 2020 | 10793 | 0.230 |
Why?
| | Cell Proliferation | 8 | 2010 | 2275 | 0.230 |
Why?
| | Interleukin-6 | 3 | 2022 | 688 | 0.230 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2022 | 32 | 0.220 |
Why?
| | Flow Cytometry | 9 | 2015 | 1085 | 0.220 |
Why?
| | Mice | 17 | 2021 | 15520 | 0.220 |
Why?
| | Smokers | 2 | 2020 | 149 | 0.220 |
Why?
| | Peripheral Tolerance | 1 | 2022 | 14 | 0.210 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 143 | 0.210 |
Why?
| | HIV Core Protein p24 | 5 | 2010 | 28 | 0.210 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2022 | 175 | 0.210 |
Why?
| | Killer Cells, Natural | 3 | 2014 | 381 | 0.210 |
Why?
| | Lymph Nodes | 3 | 2019 | 455 | 0.210 |
Why?
| | Monocytes | 4 | 2019 | 513 | 0.200 |
Why?
| | Exanthema | 1 | 2022 | 77 | 0.200 |
Why?
| | Chickenpox | 1 | 2022 | 100 | 0.200 |
Why?
| | Graft vs Host Disease | 1 | 2023 | 216 | 0.200 |
Why?
| | Immunologic Memory | 6 | 2014 | 313 | 0.200 |
Why?
| | Macaca mulatta | 5 | 2022 | 153 | 0.190 |
Why?
| | Polysaccharides, Bacterial | 2 | 2022 | 69 | 0.190 |
Why?
| | Immunity, Humoral | 1 | 2021 | 117 | 0.190 |
Why?
| | Lymphocyte Depletion | 3 | 2019 | 119 | 0.190 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 4 | 2019 | 29 | 0.190 |
Why?
| | Lung Diseases | 3 | 2017 | 717 | 0.190 |
Why?
| | Pneumocystis | 2 | 1996 | 6 | 0.190 |
Why?
| | Integrin alpha Chains | 1 | 2020 | 22 | 0.190 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2021 | 57 | 0.190 |
Why?
| | Cell Compartmentation | 1 | 2020 | 53 | 0.180 |
Why?
| | Genome, Bacterial | 1 | 2021 | 109 | 0.180 |
Why?
| | Haplotypes | 2 | 2019 | 473 | 0.180 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 150 | 0.180 |
Why?
| | Toll-Like Receptors | 2 | 2018 | 167 | 0.180 |
Why?
| | Fetal Blood | 2 | 2014 | 272 | 0.180 |
Why?
| | Melanoma, Experimental | 1 | 2021 | 118 | 0.180 |
Why?
| | Hexosaminidases | 1 | 2019 | 17 | 0.170 |
Why?
| | CD4 Lymphocyte Count | 4 | 2013 | 267 | 0.170 |
Why?
| | HLA-DR Antigens | 4 | 2016 | 224 | 0.170 |
Why?
| | Audiovisual Aids | 1 | 2019 | 17 | 0.170 |
Why?
| | HLA-DQ Antigens | 2 | 2019 | 176 | 0.170 |
Why?
| | Prevotella | 1 | 2018 | 12 | 0.170 |
Why?
| | Cells, Cultured | 9 | 2016 | 4076 | 0.170 |
Why?
| | Multiple Myeloma | 1 | 2020 | 100 | 0.170 |
Why?
| | Genes, MHC Class II | 1 | 2019 | 72 | 0.170 |
Why?
| | Pregnancy Complications | 1 | 2023 | 448 | 0.170 |
Why?
| | Emtricitabine | 2 | 2016 | 146 | 0.170 |
Why?
| | Disease | 1 | 2019 | 98 | 0.160 |
Why?
| | Aged | 11 | 2019 | 19644 | 0.160 |
Why?
| | Virus Latency | 1 | 2019 | 84 | 0.160 |
Why?
| | Tenofovir | 2 | 2016 | 200 | 0.160 |
Why?
| | Monkey Diseases | 1 | 2018 | 21 | 0.160 |
Why?
| | Colony Count, Microbial | 1 | 2018 | 120 | 0.160 |
Why?
| | Fluorescent Antibody Technique | 4 | 2015 | 410 | 0.160 |
Why?
| | Colon | 1 | 2020 | 238 | 0.160 |
Why?
| | Cytotoxicity, Immunologic | 2 | 2015 | 204 | 0.160 |
Why?
| | Green Fluorescent Proteins | 2 | 2018 | 395 | 0.160 |
Why?
| | Neoplasm Proteins | 1 | 2021 | 400 | 0.160 |
Why?
| | Pneumonia, Pneumocystis | 2 | 1996 | 25 | 0.160 |
Why?
| | Open Reading Frames | 1 | 2018 | 121 | 0.150 |
Why?
| | CTLA-4 Antigen | 2 | 2019 | 86 | 0.150 |
Why?
| | Principal Component Analysis | 1 | 2018 | 180 | 0.150 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2018 | 84 | 0.150 |
Why?
| | Case-Control Studies | 7 | 2020 | 3171 | 0.150 |
Why?
| | In Vitro Techniques | 1 | 2019 | 1094 | 0.150 |
Why?
| | Melanoma | 3 | 2008 | 664 | 0.150 |
Why?
| | Vaccines, DNA | 1 | 2016 | 32 | 0.150 |
Why?
| | Skin | 2 | 2019 | 657 | 0.150 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 112 | 0.150 |
Why?
| | Genitalia | 1 | 2016 | 27 | 0.140 |
Why?
| | Mice, Knockout | 5 | 2021 | 2680 | 0.140 |
Why?
| | Immunization, Secondary | 1 | 2016 | 85 | 0.140 |
Why?
| | Antigen Presentation | 1 | 2017 | 194 | 0.140 |
Why?
| | Withholding Treatment | 1 | 2016 | 67 | 0.140 |
Why?
| | Immune Tolerance | 2 | 2016 | 334 | 0.140 |
Why?
| | Biopsy | 1 | 2020 | 1079 | 0.140 |
Why?
| | Hepatitis C | 2 | 2009 | 217 | 0.140 |
Why?
| | Mouth | 1 | 2015 | 74 | 0.130 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2016 | 355 | 0.130 |
Why?
| | Immune Evasion | 1 | 2015 | 48 | 0.130 |
Why?
| | Retroviridae Infections | 1 | 2015 | 46 | 0.130 |
Why?
| | Rectum | 1 | 2016 | 157 | 0.130 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2016 | 177 | 0.130 |
Why?
| | Survivors | 2 | 2016 | 416 | 0.130 |
Why?
| | Cytomegalovirus Infections | 2 | 2015 | 187 | 0.130 |
Why?
| | Transplantation, Homologous | 1 | 2016 | 415 | 0.130 |
Why?
| | Immune Reconstitution Inflammatory Syndrome | 1 | 2014 | 18 | 0.130 |
Why?
| | Adolescent | 5 | 2020 | 18480 | 0.130 |
Why?
| | Software | 1 | 2019 | 613 | 0.130 |
Why?
| | Inflammation Mediators | 1 | 2018 | 502 | 0.130 |
Why?
| | Immunotherapy | 1 | 2019 | 493 | 0.130 |
Why?
| | Macrophages | 4 | 2015 | 1324 | 0.130 |
Why?
| | Organophosphonates | 1 | 2015 | 94 | 0.120 |
Why?
| | Deoxycytidine | 1 | 2015 | 136 | 0.120 |
Why?
| | Mortality | 1 | 2016 | 299 | 0.120 |
Why?
| | Biomarkers | 6 | 2019 | 3588 | 0.120 |
Why?
| | Physical Fitness | 1 | 2015 | 179 | 0.120 |
Why?
| | Immunization | 2 | 2008 | 412 | 0.120 |
Why?
| | Receptors, Interleukin-1 | 1 | 2015 | 228 | 0.120 |
Why?
| | DNA, Ribosomal | 1 | 2013 | 79 | 0.120 |
Why?
| | Tropheryma | 1 | 2013 | 4 | 0.120 |
Why?
| | Whipple Disease | 1 | 2013 | 5 | 0.120 |
Why?
| | Adenine | 1 | 2015 | 223 | 0.110 |
Why?
| | Leukocyte Common Antigens | 3 | 2011 | 76 | 0.110 |
Why?
| | Galectins | 1 | 2013 | 23 | 0.110 |
Why?
| | Mice, Inbred BALB C | 3 | 2012 | 1206 | 0.110 |
Why?
| | Smoking | 1 | 2020 | 1487 | 0.110 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2015 | 174 | 0.110 |
Why?
| | 4-1BB Ligand | 2 | 2009 | 6 | 0.110 |
Why?
| | Hematopoiesis | 2 | 2011 | 175 | 0.110 |
Why?
| | Disease Models, Animal | 6 | 2019 | 3730 | 0.110 |
Why?
| | Cytomegalovirus | 3 | 2015 | 144 | 0.110 |
Why?
| | Receptors, CXCR4 | 2 | 2010 | 81 | 0.100 |
Why?
| | Interleukins | 1 | 2013 | 242 | 0.100 |
Why?
| | Neovascularization, Pathologic | 1 | 2013 | 287 | 0.100 |
Why?
| | Sequence Analysis, DNA | 2 | 2013 | 755 | 0.100 |
Why?
| | Prognosis | 2 | 2017 | 3440 | 0.100 |
Why?
| | Interleukin Receptor Common gamma Subunit | 1 | 2011 | 15 | 0.100 |
Why?
| | RNA, Viral | 3 | 2004 | 572 | 0.100 |
Why?
| | Th1 Cells | 2 | 2013 | 133 | 0.100 |
Why?
| | Cell Line | 5 | 2018 | 2707 | 0.100 |
Why?
| | CCR5 Receptor Antagonists | 1 | 2010 | 6 | 0.090 |
Why?
| | Ecology | 1 | 2011 | 104 | 0.090 |
Why?
| | Metagenome | 1 | 2011 | 121 | 0.090 |
Why?
| | Motor Activity | 1 | 2015 | 660 | 0.090 |
Why?
| | Lymphocyte Count | 4 | 2017 | 136 | 0.090 |
Why?
| | Ligands | 2 | 2014 | 567 | 0.090 |
Why?
| | Forkhead Transcription Factors | 2 | 2010 | 182 | 0.090 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 1136 | 0.090 |
Why?
| | Hydroxamic Acids | 1 | 2010 | 80 | 0.090 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2275 | 0.090 |
Why?
| | Skin Neoplasms | 2 | 2007 | 762 | 0.090 |
Why?
| | Molecular Sequence Data | 2 | 2013 | 2869 | 0.090 |
Why?
| | Vagina | 1 | 2011 | 148 | 0.090 |
Why?
| | OX40 Ligand | 1 | 2009 | 10 | 0.090 |
Why?
| | Antibodies, Monoclonal | 5 | 2020 | 1284 | 0.090 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2009 | 27 | 0.090 |
Why?
| | T-Lymphocytes, Helper-Inducer | 2 | 2007 | 130 | 0.090 |
Why?
| | Cell Lineage | 1 | 2011 | 317 | 0.090 |
Why?
| | Risk Factors | 2 | 2020 | 8998 | 0.090 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 967 | 0.090 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2009 | 79 | 0.080 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2010 | 200 | 0.080 |
Why?
| | Myeloid Cells | 1 | 2009 | 128 | 0.080 |
Why?
| | Convalescence | 1 | 2007 | 15 | 0.080 |
Why?
| | Cell Division | 2 | 2013 | 776 | 0.080 |
Why?
| | Antibodies, Blocking | 1 | 2007 | 32 | 0.080 |
Why?
| | Homeodomain Proteins | 1 | 2011 | 468 | 0.080 |
Why?
| | Genes, tat | 1 | 2007 | 2 | 0.080 |
Why?
| | Genes, rev | 1 | 2007 | 2 | 0.080 |
Why?
| | Tumor Escape | 1 | 2007 | 38 | 0.080 |
Why?
| | Arthritis, Experimental | 1 | 2009 | 133 | 0.080 |
Why?
| | Gene Expression Regulation | 4 | 2019 | 2445 | 0.070 |
Why?
| | Cystatins | 1 | 2006 | 7 | 0.070 |
Why?
| | Bronchoalveolar Lavage | 1 | 2007 | 89 | 0.070 |
Why?
| | Prospective Studies | 4 | 2016 | 6471 | 0.070 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2007 | 83 | 0.070 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2006 | 102 | 0.070 |
Why?
| | RNA, Catalytic | 1 | 2007 | 182 | 0.070 |
Why?
| | Receptors, CCR7 | 1 | 2005 | 24 | 0.070 |
Why?
| | Ecosystem | 1 | 2011 | 555 | 0.070 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2005 | 41 | 0.070 |
Why?
| | Receptors, Chemokine | 1 | 2005 | 45 | 0.070 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2023 | 540 | 0.070 |
Why?
| | Analysis of Variance | 1 | 2009 | 1293 | 0.070 |
Why?
| | Interleukin-1beta | 2 | 2021 | 379 | 0.070 |
Why?
| | Signal Transduction | 4 | 2021 | 4709 | 0.070 |
Why?
| | Hepacivirus | 1 | 2007 | 230 | 0.070 |
Why?
| | Hepatitis C, Chronic | 1 | 2007 | 151 | 0.070 |
Why?
| | Host-Pathogen Interactions | 2 | 2019 | 300 | 0.060 |
Why?
| | United States | 1 | 2021 | 12541 | 0.060 |
Why?
| | Neoplasms | 1 | 2019 | 2177 | 0.060 |
Why?
| | RNA, Small Interfering | 1 | 2007 | 564 | 0.060 |
Why?
| | Programmed Cell Death 1 Ligand 2 Protein | 2 | 2019 | 14 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2017 | 2210 | 0.060 |
Why?
| | Mice, Inbred C57BL | 4 | 2019 | 4908 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2015 | 333 | 0.060 |
Why?
| | Antigens, CD34 | 3 | 2011 | 98 | 0.060 |
Why?
| | Pulmonary Fibrosis | 1 | 2006 | 303 | 0.060 |
Why?
| | DNA-Binding Proteins | 2 | 2011 | 1346 | 0.060 |
Why?
| | Lipopolysaccharides | 2 | 2019 | 870 | 0.060 |
Why?
| | Immunoglobulin Isotypes | 1 | 2022 | 32 | 0.060 |
Why?
| | CD4 Antigens | 3 | 2007 | 126 | 0.060 |
Why?
| | Immunoglobulin D | 1 | 2022 | 28 | 0.060 |
Why?
| | Cell Differentiation | 2 | 2015 | 1752 | 0.050 |
Why?
| | Bacteroides fragilis | 1 | 2022 | 11 | 0.050 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 1 | 2002 | 83 | 0.050 |
Why?
| | Lectins, C-Type | 1 | 2002 | 63 | 0.050 |
Why?
| | Mice, SCID | 2 | 2007 | 333 | 0.050 |
Why?
| | Longitudinal Studies | 3 | 2018 | 2513 | 0.050 |
Why?
| | Cell Count | 2 | 2016 | 315 | 0.050 |
Why?
| | Interferons | 1 | 2022 | 151 | 0.050 |
Why?
| | Allergens | 1 | 2005 | 424 | 0.050 |
Why?
| | Hypersensitivity | 1 | 2005 | 268 | 0.050 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 2 | 2003 | 310 | 0.050 |
Why?
| | CD28 Antigens | 2 | 2013 | 46 | 0.050 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2002 | 224 | 0.050 |
Why?
| | Vaccines, Synthetic | 1 | 2021 | 128 | 0.050 |
Why?
| | Transforming Growth Factor beta | 3 | 2008 | 462 | 0.050 |
Why?
| | Immunity | 1 | 2021 | 129 | 0.050 |
Why?
| | Species Specificity | 2 | 2016 | 565 | 0.050 |
Why?
| | Phenotype | 3 | 2019 | 3003 | 0.050 |
Why?
| | Arthritis, Rheumatoid | 1 | 2009 | 988 | 0.050 |
Why?
| | Proteasome Inhibitors | 1 | 2020 | 44 | 0.050 |
Why?
| | Mice, Transgenic | 2 | 2019 | 2025 | 0.050 |
Why?
| | Bacteroides | 1 | 2019 | 18 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2019 | 6555 | 0.040 |
Why?
| | B7-2 Antigen | 2 | 2013 | 25 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2019 | 2656 | 0.040 |
Why?
| | Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1999 | 26 | 0.040 |
Why?
| | Genes, T-Cell Receptor beta | 1 | 1999 | 19 | 0.040 |
Why?
| | Fetus | 1 | 2023 | 689 | 0.040 |
Why?
| | Ganglia | 1 | 2019 | 30 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2015 | 1691 | 0.040 |
Why?
| | Spondylarthritis | 1 | 2019 | 35 | 0.040 |
Why?
| | Survival Rate | 2 | 2017 | 1720 | 0.040 |
Why?
| | HLA-DQ beta-Chains | 1 | 2019 | 61 | 0.040 |
Why?
| | Coinfection | 1 | 2020 | 119 | 0.040 |
Why?
| | Macrophages, Peritoneal | 1 | 2019 | 96 | 0.040 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2010 | 71 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2019 | 208 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2019 | 103 | 0.040 |
Why?
| | Protein Transport | 1 | 2019 | 412 | 0.040 |
Why?
| | Genetic Loci | 1 | 2019 | 281 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 187 | 0.040 |
Why?
| | Antigen-Presenting Cells | 1 | 2017 | 156 | 0.040 |
Why?
| | Cell Communication | 1 | 2018 | 281 | 0.040 |
Why?
| | Virus Diseases | 1 | 2019 | 198 | 0.040 |
Why?
| | Adventitia | 1 | 2016 | 39 | 0.040 |
Why?
| | Membrane Glycoproteins | 2 | 2013 | 446 | 0.040 |
Why?
| | Sheep | 1 | 1999 | 764 | 0.040 |
Why?
| | Life Style | 1 | 2018 | 430 | 0.040 |
Why?
| | Morbidity | 1 | 2017 | 296 | 0.030 |
Why?
| | Spermatozoa | 1 | 2016 | 91 | 0.030 |
Why?
| | Viral Proteins | 1 | 2018 | 296 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2019 | 580 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2019 | 5255 | 0.030 |
Why?
| | Neuroglia | 1 | 2016 | 157 | 0.030 |
Why?
| | Virulence | 1 | 1996 | 240 | 0.030 |
Why?
| | Retroviridae | 1 | 2015 | 89 | 0.030 |
Why?
| | Vero Cells | 1 | 2015 | 69 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 827 | 0.030 |
Why?
| | HIV Antigens | 1 | 2015 | 17 | 0.030 |
Why?
| | Immobilized Proteins | 1 | 2015 | 12 | 0.030 |
Why?
| | Neutralization Tests | 1 | 2015 | 66 | 0.030 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2019 | 290 | 0.030 |
Why?
| | Blood Cells | 1 | 2014 | 39 | 0.030 |
Why?
| | NF-kappa B | 1 | 2019 | 670 | 0.030 |
Why?
| | Mice, Nude | 1 | 1996 | 663 | 0.030 |
Why?
| | Autoantibodies | 1 | 2022 | 1335 | 0.030 |
Why?
| | Enhancer Elements, Genetic | 1 | 2016 | 152 | 0.030 |
Why?
| | Safety | 1 | 2016 | 304 | 0.030 |
Why?
| | Lymphocyte Subsets | 1 | 2014 | 76 | 0.030 |
Why?
| | Global Health | 1 | 2017 | 310 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2020 | 900 | 0.030 |
Why?
| | Extracellular Space | 1 | 2015 | 127 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2017 | 454 | 0.030 |
Why?
| | Endostatins | 1 | 2013 | 11 | 0.030 |
Why?
| | Activins | 1 | 2013 | 26 | 0.030 |
Why?
| | Endotoxemia | 1 | 2015 | 93 | 0.030 |
Why?
| | Colitis | 1 | 2016 | 219 | 0.030 |
Why?
| | Integrin alphaVbeta3 | 1 | 2013 | 25 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 285 | 0.030 |
Why?
| | Recurrence | 1 | 2016 | 975 | 0.030 |
Why?
| | Nitrogen Oxides | 1 | 2013 | 56 | 0.030 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2013 | 103 | 0.030 |
Why?
| | Genotype | 1 | 2019 | 1881 | 0.030 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2013 | 36 | 0.030 |
Why?
| | B7-1 Antigen | 1 | 2013 | 69 | 0.030 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2013 | 127 | 0.030 |
Why?
| | Muromegalovirus | 1 | 2013 | 13 | 0.030 |
Why?
| | Lymphokines | 1 | 2013 | 122 | 0.030 |
Why?
| | DNA, Viral | 1 | 2015 | 356 | 0.030 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2013 | 95 | 0.030 |
Why?
| | Models, Immunological | 1 | 2013 | 94 | 0.030 |
Why?
| | Prednisone | 1 | 2014 | 235 | 0.030 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2013 | 193 | 0.030 |
Why?
| | Receptors, Virus | 1 | 2013 | 78 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 828 | 0.030 |
Why?
| | Interleukin-8 | 1 | 2013 | 249 | 0.030 |
Why?
| | Interleukin-15 | 1 | 2013 | 77 | 0.030 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2013 | 164 | 0.030 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 823 | 0.030 |
Why?
| | Fibroblasts | 1 | 2016 | 842 | 0.030 |
Why?
| | Peritoneum | 1 | 2011 | 36 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2010 | 2673 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1308 | 0.030 |
Why?
| | Pregnancy | 1 | 2023 | 5690 | 0.020 |
Why?
| | Lymphoid Tissue | 1 | 2011 | 65 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2015 | 788 | 0.020 |
Why?
| | Glioblastoma | 1 | 2013 | 262 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2013 | 527 | 0.020 |
Why?
| | Immunoglobulins | 1 | 2011 | 154 | 0.020 |
Why?
| | Smad3 Protein | 1 | 2010 | 47 | 0.020 |
Why?
| | Mucous Membrane | 1 | 2011 | 113 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2016 | 963 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2017 | 1178 | 0.020 |
Why?
| | Valproic Acid | 1 | 2010 | 44 | 0.020 |
Why?
| | CD3 Complex | 1 | 2010 | 92 | 0.020 |
Why?
| | Antibody Formation | 1 | 2011 | 276 | 0.020 |
Why?
| | Immunosuppressive Agents | 1 | 2014 | 681 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2010 | 311 | 0.020 |
Why?
| | Glucocorticoids | 1 | 2014 | 545 | 0.020 |
Why?
| | Radiation Chimera | 1 | 2009 | 31 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2011 | 331 | 0.020 |
Why?
| | Radiation Injuries, Experimental | 1 | 2009 | 24 | 0.020 |
Why?
| | Mice, Inbred DBA | 1 | 2009 | 174 | 0.020 |
Why?
| | Glucocorticoid-Induced TNFR-Related Protein | 1 | 2008 | 5 | 0.020 |
Why?
| | Liver | 2 | 2007 | 1816 | 0.020 |
Why?
| | Bone Resorption | 1 | 2009 | 80 | 0.020 |
Why?
| | Mutation | 1 | 2019 | 3457 | 0.020 |
Why?
| | Alleles | 2 | 2003 | 832 | 0.020 |
Why?
| | Remission, Spontaneous | 1 | 2007 | 37 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2016 | 2061 | 0.020 |
Why?
| | Research | 1 | 2011 | 411 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2009 | 244 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 1974 | 0.020 |
Why?
| | Toll-Like Receptor 2 | 1 | 2008 | 127 | 0.020 |
Why?
| | Interleukin-3 Receptor alpha Subunit | 1 | 2007 | 16 | 0.020 |
Why?
| | Precision Medicine | 1 | 2011 | 363 | 0.020 |
Why?
| | Culture Media, Conditioned | 1 | 2007 | 112 | 0.020 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 207 | 0.020 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2007 | 158 | 0.020 |
Why?
| | Transplantation Chimera | 1 | 2007 | 51 | 0.020 |
Why?
| | Blood | 1 | 2007 | 100 | 0.020 |
Why?
| | Fibrosis | 1 | 2009 | 483 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 4705 | 0.020 |
Why?
| | Cystatin C | 1 | 2006 | 69 | 0.020 |
Why?
| | CD8 Antigens | 1 | 2006 | 71 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2007 | 215 | 0.020 |
Why?
| | Gene Silencing | 1 | 2007 | 177 | 0.020 |
Why?
| | Transplantation, Heterologous | 1 | 2006 | 194 | 0.020 |
Why?
| | Bacillus subtilis | 1 | 2006 | 61 | 0.020 |
Why?
| | Thymus Gland | 1 | 2007 | 300 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2007 | 302 | 0.020 |
Why?
| | Time Factors | 1 | 2016 | 6409 | 0.020 |
Why?
| | Toll-Like Receptor 4 | 1 | 2008 | 330 | 0.020 |
Why?
| | Immunity, Cellular | 1 | 2007 | 270 | 0.020 |
Why?
| | Infant | 1 | 2019 | 8293 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2007 | 369 | 0.020 |
Why?
| | Child, Preschool | 1 | 2019 | 9491 | 0.020 |
Why?
| | Brain | 1 | 2016 | 2489 | 0.020 |
Why?
| | Apoptosis | 1 | 2013 | 2484 | 0.020 |
Why?
| | Aging | 1 | 2014 | 1669 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 2007 | 1221 | 0.010 |
Why?
| | HLA-DRB1 Chains | 1 | 2003 | 97 | 0.010 |
Why?
| | Clone Cells | 1 | 2003 | 248 | 0.010 |
Why?
| | Hypertension, Pulmonary | 1 | 2013 | 1794 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2003 | 219 | 0.010 |
Why?
| | CD40 Antigens | 1 | 2002 | 80 | 0.010 |
Why?
| | Child | 1 | 2019 | 19128 | 0.010 |
Why?
| | Consensus Sequence | 1 | 1999 | 70 | 0.010 |
Why?
| | Germ Cells | 1 | 1999 | 64 | 0.010 |
Why?
| | DNA, Complementary | 1 | 1999 | 268 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1999 | 335 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1999 | 371 | 0.010 |
Why?
| | Disease Progression | 1 | 2005 | 2490 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1999 | 545 | 0.010 |
Why?
| | Protein Binding | 1 | 2003 | 1975 | 0.010 |
Why?
| | Opportunistic Infections | 1 | 1996 | 42 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1999 | 1012 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 1999 | 642 | 0.010 |
Why?
| | Base Sequence | 1 | 1999 | 2158 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1999 | 2070 | 0.010 |
Why?
| | Genetic Variation | 1 | 1999 | 926 | 0.010 |
Why?
|
|
Palmer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|